Are peptides legal in Mexico?
Sourced guide to the legal status of peptides in Mexico, refreshed automatically from live research.
Overall Status: Restricted
Short answer: Peptides are restricted in Mexico to a prescription/compounding-pharmacy pathway: unapproved research peptides such as BPC-157 or TB-500 have no COFEPRIS sanitary registration and can only be legally supplied by a licensed 'farmacia magistral' compounding pharmacy against a patient-specific prescription, while industrially manufactured peptide drugs like semaglutide require full COFEPRIS registration to be sold as commercial medicines.
Important: This information is for educational purposes only and does not constitute legal advice. Laws and enforcement policies change. Consult a qualified attorney for specific legal guidance.
Overview
Peptides are restricted in Mexico rather than freely sold over the counter: most research/regenerative peptides (e.g., BPC-157, TB-500) are not individually approved medicines with their own sanitary registration, so they are legally accessed only through compounding pharmacies operating under a physician's prescription. Mexico's national health regulator, COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios), governs both pathways under the General Health Law (Ley General de Salud) and the Reglamento de Insumos para la Salud: compounded, patient-specific preparations fall under the 'farmacia magistral' model, while mass-manufactured peptide drugs sold commercially (such as GLP-1 medicines) must carry a COFEPRIS sanitary registration. This creates a two-track system: a prescription/compounding lane for individualized peptide preparations, and a full drug-approval lane for industrially produced peptide pharmaceuticals.
Key Points
- COFEPRIS is the national regulator that oversees both compounded peptide preparations and industrially manufactured peptide medicines in Mexico under the General Health Law and the Reglamento de Insumos para la Salud. [1]
- Research/regenerative peptides such as BPC-157 and TB-500 generally lack their own COFEPRIS sanitary registration in Mexico and are instead compounded for individual patients under a 'farmacia magistral' (master pharmacy) model that requires a written prescription. [1]
- A farmacia magistral in Mexico must itself hold a valid COFEPRIS sanitary license and follow Good Compounding Practices, documenting each individualized peptide preparation it dispenses. [1]
- Peptide drugs manufactured at industrial scale and sold as commercial therapies in Mexico, such as GLP-1 medicines, require full COFEPRIS sanitary registration involving quality controls, pharmacovigilance, and manufacturer-to-patient traceability, rather than being sold as unregulated research chemicals. [1]
- No COFEPRIS public bulletin, gazette notice, or enforcement action specifically naming BPC-157, TB-500, or 'research peptides' as banned or scheduled substances could be located, so their status rests on the general compounding/registration framework rather than a peptide-specific rule. (No reliable source found for this point -- flagged as unverified rather than stated as fact.)
- Personal importation rules for peptides into Mexico (e.g., carrying a personal supply of BPC-157 or semaglutide across the border) were not found in a specific COFEPRIS or Mexican customs (Aduanas) publication during this research, so travelers should not assume unrestricted personal-use import is guaranteed without a prescription. (No reliable source found for this point -- flagged as unverified rather than stated as fact.)
- No specific enforcement actions, recalls, or regulatory changes from the last 2-3 years targeting peptides or research chemicals in Mexico were found in this research; this is an information gap rather than evidence that no such actions exist. (No reliable source found for this point -- flagged as unverified rather than stated as fact.)
Peptide-by-peptide status in Mexico
| BPC-157 | BPC-157 has no independent COFEPRIS sanitary registration as a medicine in Mexico, so it can only be legally supplied through a compounding ('farmacia magistral') pharmacy against a physician's prescription rather than sold as an over-the-counter research chemical. [1] |
|---|
| TB-500 | TB-500, like other unregistered regenerative peptides, falls under the same compounding-pharmacy/prescription framework in Mexico rather than having its own COFEPRIS drug approval, based on the general peptide-compounding rules described for the Mexican market. [1] |
|---|
| Semaglutide (GLP-1 class) | Semaglutide-class GLP-1 medicines sold commercially in Mexico must carry full COFEPRIS sanitary registration as industrially manufactured drugs, distinguishing them from compounded research peptides that lack such registration. [1] |
|---|
| Human Growth Hormone (HGH/somatropin) | No Mexico-specific primary source on HGH/somatropin's exact legal classification was found in this research, so its status cannot be confirmed here beyond the general expectation that, as a biological medicine, it would fall under COFEPRIS sanitary registration and prescription requirements rather than unregulated research-chemical sale. |
|---|
Last researched: 2026-09-10
Frequently asked questions
No lawful over-the-counter sale of BPC-157 was documented in this research; in Mexico it is meant to be dispensed only by a licensed compounding pharmacy ('farmacia magistral') against a physician's prescription, since it lacks its own COFEPRIS sanitary registration as a commercial medicine.
[1]
A specific Mexican customs or COFEPRIS rule on personal importation of peptides was not found in this research, so travelers should not assume unrestricted personal import of unregistered peptides is guaranteed; carrying a valid prescription is the safest documented pathway given the country's prescription/compounding framework for these products.
No specific Mexican telehealth-prescribing rule for peptides was located in this research; the documented pathway is a written prescription supporting compounding at a licensed farmacia magistral, and whether that prescription can originate from a telehealth consultation was not confirmed by a primary source.
No specific penalty case or enforcement bulletin against unauthorized peptide sales in Mexico was found in this research, so the practical enforcement consequences (fines, closures, or criminal referral) cannot be confirmed here beyond the general requirement that compounding pharmacies and drug sellers hold valid COFEPRIS sanitary licenses.
[1]
Yes, semaglutide is legal in Mexico as a registered pharmaceutical, but as an industrially manufactured medicine it must carry a full COFEPRIS sanitary registration and would be expected to require a prescription for lawful sale, unlike unregistered compounded research peptides.
[1]